1 Up to now, approximately 40 lamellarins have been isolated from mollusks, tunicates, and sponges.
2 These differ in the number and position of the OH and OMe groups on the common structural core. Lamellarins exhibit a wide range of useful biological activities; most notable is potent cytotoxic activity against cancer cell lines, including the MDR phenotype. 3 Extensive studies on structure-activity relationship have revealed the structural requirements for the cytotoxicity. 4 Multiple cellular targets, such as DNA topoisomerase I, 5 cancerrelevant protein kinases, 6 and mitochondria, 7 have been discovered. Some lamellarin derivatives are currently under preclinical development as anti-cancer agents. 8 Anti-HIV-1 activity is another important biological effect of lamellarins. Faulkner and coworkers screened diverse natural marine products for compounds active against HIV-1 integrase in vitro and found that some lamellarins showed selective inhibition for this enzyme. 9 Within the series of lamellarins tested, lamellarin α 20-sulfate displayed the most favorable therapeutic index. This compound inhibited integrase terminal cleavage activity with an IC 50 of 16 µM, strand transfer activity with an IC 50 of 22 µM, and growth of the HIV-1 virus in cell culture with an IC 50 of 8 µM. The MTT assay of lamellarin α 20-sulfate toward HeLa cells displayed the least toxicity of 274 µM.
Despite the promising feature of lamellarin α 20-sulfate as a new lead anti-HIV-1 agent, the structure-activity relationships of lamellarin sulfates have scarcely been investigated. 10 This is presumably due to the lack of a methodology for the synthesis of regioselectively sulfated lamellarins. Recently, however, we have developed a method to overcome this problem and achieved the first total synthesis of lamellarin α 20-sulfate 11 and related compounds. 12 In the present study, we have synthesized nonsulfated lamellarin α (1) and six different types of sulfated lamellarins 2-7 and investigated the structure-activity relationships using single-round HIV-1 vector infection assay. A plausible mechanism of action of the lamellarin sulfates in vivo is also proposed.
Results and discussion

Synthesis
The synthesis of lamellarin α (1), ring-opened lamellarin sulfate (2), lamellarin U 20-sulfate (3), lamellarin α 20-sulfate (4) , and lamellarin α 13-sulfate (5) is show in Scheme 1. Palladium-catalyzed Suzuki-Miyaura coupling of the known 3,4-dihydroxypyrrole bistriflate 8 13 with 1.2 equiv of arylboronic acid 9 gave the mono-arylated pyrrole 10 in 77% yield. This compound was converted to 11 in 96% yield by deprotection of the methoxymethyl (MOM) group followed by acid-catalyzed lactonization. The second Suzuki-Miyaura coupling of 11 with 1.3 equiv of pinacol borate 12 gave 3,4-differentially arylated pyrrole 13 in 94% yield. Alkaline hydrolysis of 13 followed by pyridinium p-toluenesulfonate (PPTS)-catalyzed relactonization afforded the acid 14 in 73 % yield. Decarboxylation of 14 in hot quinoline in the presence of copper (I) oxide provided 15 in nearly quantitative yield. Intramolecular oxidative biaryl coupling 14 of 15 in the presence of phenyliodine bis(trifluoroacetate) (PIFA)-borontrifluoride etherate gave the lamellarin framework 16 in 54% yield. Treatment of this compound with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) in refluxing dichloromethane afforded 5,6-unsaturated lamellarin 17 in 87% yield. Simultaneous deprotection of both benzyl and MOM groups with 6 equiv of boron trichloride produced lamellarin α (1) in 98% yield.
Regioselective installation of the sulfate group onto the heterocyclic scaffold of 15, 16, and 17 was effected by selective removal of the benzyl or MOM protecting group under different conditions followed by sulfation utilizing the Taylor protocol. 15 For example, the sulfate 2 was synthesized from 15 in four steps as follows. Debenzylation of 15 under hydrogen atmosphere in 27 (R 1 = Bn, R 2 = H) (j) 25 (R 1 = SO 3 CH 2 CCl 3 , R 2 = MOM) 26 (R 1 = SO 3 CH 2 CCl 3 , R 2 = H) (k) 4 (R 1 = SO 3 Na, R 2 = H) (l) (4) were synthesized using similar transformations starting from 16 and 17, respectively. Lamellarin α 13-sulfate (5), on the other hand, was synthesized by initial deprotection of MOM followed by 2,2,2-trichloroethoxysulfonylation, debenzylation by boron trichloride, and a final reductive removal of TCE moiety.
Lamellarin α 13,20-disulfate (6) and lamellarin N 8,13,20-trisulfate (7) were synthesized in good yields from lamellarin α (1) and lamellarin N (30), respectively, by treatment with conventional pyridine·SO 2 complex (Scheme 2). 
Anti-HIV-1 evaluation
The anti-HIV-1 activity of lamellarins 1-7 was estimated at first by single-round HIV-1 vector infection assays 16 on HeLa/CD4 cells (see Experimental section). The IC 50 values estimated from dose-response curves are summarized in Table 1 . Both non-sulfated lamellarin α (1) and the ring-opened sulfate (2) did not show anti-HIV-1 activity at 100 µM (entries 1 and 2). On the other hand, sulfates 3-7 exhibited anti-HIV-1 activities at a 10 µM concentration range (entries 3-7). When the target cells were treated with these compounds at 100 µM, the infected cells were not detected. These results indicated that the presence of both the pentacyclic lamellarin core and the sulfate group is an essential structural requirement for the anti-HIV-1 activity of lamellarins. Other structural elements, such as saturation or unsaturation between C6 and C7 bond (entries 3 and 4), position of the sulfate group in the lamellarin ring (entries 4 and 5), and the number of sulfate groups (entries 4, 5, 6, and 7) are relatively less important. It has been reported that the parental non-sulfated lamellarins exhibit potent cytotoxicity on a variety of cancer cell lines via multiple mechanism of action.
5-7 Therefore, we performed WST-1 assays to estimate the cytotoxicity of lamellarin sulfates 3-7. HeLa/CD4 cells were incubated with these compounds at 100 µM for 24 h prior to assay. No sulfates tested exhibited unfavorable cytotoxicity, at least under these conditions (Table 1 ).
The lack of cytotoxicity of sulfates 3-7 suggested that these hydrophilic compounds are not incorporated in HeLa/CD4 cells. Recently, Cushman et al. demonstrated by LC-MS-MS analysis that resveratrol sulfates, which are structurally similar to lamellarin sulfates, displayed negligible uptake in MCF7 cells. 17 Lamellarins are UV fluorescent ( Figure S2 in supplementary data). Therefore, we examined cellular uptake of lamellarin sulfates using a confocal laser scanning microscope. HeLa/CD4 cells were treated with lamellarins 1, 3-7 at 100 µM for 24 h. After washing with phosphate-buffered saline (PBS) and fixing in 4% paraformaldehyde, the resulting cells were observed by a confocal laser scanning microscope. The fluorescent signal corresponding to the lamellarin framework was observed in the cells treated with lamellarin α (1) (Figure 2, A) . 18 However, no fluorescent signals were detected in the cells treated with lamellarin sulfates 3-7 (Figure 2 , B-F). For comparison, similar experiments were carried out after permeabilization of the cell membrane with methanol. In these cases, fluorescent signals were observed in all cells treated with both lamellarin α (1) and lamellarin sulfates 3-7 (Figure 2 , G-L). These results clearly indicate that hydrophilic lamellarin sulfates 3-7 do not pass through the hydrophobic cell membrane.
Inaccessibility of lamellarin sulfates into HeLa/CD4 cells suggested that these compounds inhibit HIV-1 infection at the virus entry step rather than at the later integration step. HIV-1 gains entry into susceptible cells by fusion of the viral membrane with the cell plasma membrane. 19 The membrane fusion process between HIV-1 and target cells is initiated by the attachment of HIV-1 envelope glycoprotein (Env) to the receptors on the target cell membrane. 20 The HIV-1 Env-expressing cells can fuse with susceptible cells by the membrane fusion activity of the Env protein. 21, 22 It is thought that the cell-cell fusion by the Env protein reflects the membrane fusion between virions and target cells. 23, 24 Thus, we examined the inhibitory effect of lamellarin sulfates on the HIV-1 Env-mediated cell-cell fusion using a coculture system of MAGIC 5 target cells and HIV-1 Envexpressing 293T effector cells. The degree of inhibition was estimated by measuring the β-galactosidase activities of the cell lysates. The effects of lamellarin sulfates are summarized as a bar graph in Figure 3 . Bar 1 indicates a negative control in which Env-non-expressing effector cells (no ability of cell-cell fusion) were employed. Bar 2 shows a positive control in which Envexpressing effector cells were employed in the absence of inhibitors. On treatment with lamellarin sulfates 3-7 at 100 µM (bars 3-7), the β-galactosidase activities of the co-culture systems were reduced to the same as that of the negative control. In contrast, on treatment with ring-opened sulfate 2 at the same concentration (bar 8), the β-galactosidase activity was increased to the level of positive control. These results clearly indicate that lamellarin sulfates 3-7 inhibited cell-cell fusion at 100 µM, whereas ring-opened analogue 2 did not. The good correlation between the inhibitory effects on HIV-1 infection and on HIV-1 Env-mediated cell-cell fusion suggested that the mechanism of action of lamellarin sulfates is entry inhibition rather than integrase inhibition.
Conclusion
A small library of anti-HIV-1 lamellarin α 20-sulfate analogues was prepared using a synthetic strategy developed in our laboratories. The structure-activity relationship study revealed that the pentacyclic lamellarin core and the sulfate group are essential for anti-HIV-1 activity. Confocal laser microscopic analyses and cell-cell fusion experiments suggested that the anti-HIV-1 activity of lamellarin sulfates are caused by inhibition of the virus entry step rather than the previously indicated integration step. Melting points are uncorrected. IR spectra are reported in terms of frequency of absorption (cm -1 ). 1 H NMR spectra were recorded at 400 MHz and are reported relative to Me 4 Si (δ 0.0). Data for 1 H NMR spectra are reported as follows: chemical shift (δ ppm), multiplicity, coupling constant (Hz) and integration.
Experimental section
Synthesis-general
13 C NMR spectra were recorded at 100 MHz and are reported relative to Me 4 Si (δ 0.0). Data for 13 C NMR spectra are reported in terms of chemical shift. High resolution mass spectra were measured by the EI or FAB method. Elemental analysis was performed for C, H, and N. Column chromatography was conducted on silica gel 60N, 63-210 µm unless otherwise mentioned. Solvents were dried and distilled by standard methods if necessary. Under an argon atmosphere, a mixture of 8 (12.9 g, 20.0 mmol), 9 (7.64 g, 24.0 mmol), Pd(PPh 3 ) 4 (462 mg, 0.400 mmol), Na 2 CO 3 (14.0 g, 132 mmol), and degassed water (40 mL) in THF (400 mL) was refluxed for 3 h. The mixture was cooled to room temperature and evaporated. The products were extracted with dichloromethane and the extract was washed successively with water and brine, dried over Na 2 SO 4 , and evaporated. The residue was purified by column chromatography (toluene-ethyl acetate = 10:1) to give 10 as pale brown solid (11.8 g, 77% To a solution of 10 (11.8 g, 15.3 mmol) in methanol (1.0 L) was added concd HCl (100 mL) at room temperature. After being refluxed for 3 h, the mixture was cooled to room temperature and evaporated. The residue was poured into water (200 mL) and the precipitates thus formed was collected by filtration, washed with water, and dried under reduced pressure. On the other hand, the filtrate was extracted with dichloromethane and the extract was washed with water and brine, dried over Na 2 SO 4 , and evaporated to give an additional demethoxymethylated product. The demethoxymethylated product was dissolved in dichloromethane (800 mL) and p-toluenesulfonic acid monohydrate (729 mg, 3.83 mmol) was added. The mixture was refluxed for 3.5 h, cooled to room temperature, washed with saturated aqueous NaHCO 3 and brine, dried over Na 2 SO 4 , and evaporated. The residue was purified by column chromatography (dichloromethane) to give 11 as colorless solid (10.2 g, 96% 7-benzyloxy-3-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dihydro-8-methoxy-1-[4-methoxy-3-(methoxymethoxy)phenyl]-4-oxo-[1]benzopyrano[3,4 b]pyrrole-2-carboxylate (13) According to the procedure described for the preparation of compound 10, 11 (5. 
Synthesis of lamellarin
7.36-7.42 (m, 2H), 7.38 (s, 1H), 7.43-7.48 (m, 2H); 13 C NMR (100 MHz, CDCl 3 ) δ 37.6, 48.7, 52.4, 55.8, 55.9, 56.3, 71.1, 102.7
Methyl
45 g, 7.89 mmol), 12 (3.02 g, 10.3 mmol), and Pd(PPh 3 ) 4 (182 mg, 0.158 mmol) were reacted for 3 h. After chromatographic purification (hexane-ethyl acetate = 1:1-1:2), 13 was obtained as colorless solid (5.24 g, 94%
7-Benzyloxy-3-[2-(3,4-dimethoxyphenyl)ethyl]-8-methoxy-1-[4-methoxy-3-(methoxymethoxy)phenyl]-4-oxo-3,4-dihydro-[1]benzopyrano[3,4-b]pyrrole-2-carboxylic acid (14)
Under an argon atmosphere, a suspension of 13 (3.55 g, 5.00 mmol) in a degassed mixture of 40% aqueous KOH (200 mL) and ethanol (200 mL) was refluxed for 2 h. The solution was cooled to room temperature and concentrated. The pH of the solution was adjusted with acetic acid (225 mL) and the product was extracted with dichloromethane. The extract was washed with water and brine, dried over Na 2 SO 4 , and evaporated. The residue was dissolved in dichloromethane (500 mL) and PPTS (1.26 g, 5.00 mmol) was added. The mixture was refluxed for 8 h, cooled to room temperature, and evaporated. The residue was purified by column chromatography (dichloromethane-methanol = 10:1) to give 14 as pale brown solid (2.53 g, 73% 
7-Benzyloxy-3-[2-(3,4-dimethoxyphenyl)ethyl]-8-methoxy-1-[4-methoxy-3-(methoxymethoxy)phenyl]-[1]benzopyrano[3,4-b]pyrrol-4(3H)-one (15)
Under an argon atmosphere, a mixture of 14 (1.74 g, 2.50 mmol) and copper(I) oxide (358 mg, 2.50 mmol) in quinoline (25 mL) was heated at 220 °C for 10 min. The mixture was cooled to room temperature and evaporated. The residue was diluted with dichloromethane and the mixture was passed through a pad of Celite. The filtrate was washed with 1 M HCl, saturated aqueous NaHCO 3 , water, and brine, dried over Na 2 SO 4 , and evaporated. The residue was purified by column chromatography (hexaneethyl acetate = 1:1) to give 15 as pale yellow solid (1.61 g, 99% 
3-Benzyloxy-8,9-dihydro-2,11,12-trimethoxy-14-[4-methoxy-3-(methoxymethoxy)phenyl]-6H-[1]benzopyrano[4',3':4,5]pyrrolo[2,1-a]isoquinolin-6-one (16)
Under an argon atmosphere, a solution of PIFA (815 mg, 1.90 mmol) and BF 3 ·OEt 2 (480 µL, 3.89 mmol) in dichloromethane (40 mL) was added dropwise to a solution of 15 (1.03 g, 1.59 mmol) in dichloromethane (160 mL) at -40 °C. After being stirred for 1.5 h, the mixture was quenched with 2 M aqueous NH 3 and allowed to warm to room temperature. The product was extracted with dichloromethane and the extract was washed with water and brine, dried over Na 2 SO 4 , and evaporated. The residue was purified by column chromatography (dichloromethane-ethyl acetate = 20:1) to give 16 as colorless solid (552 mg, 54% 
3-Benzyloxy-2,11,12-trimethoxy-14-[4-methoxy-3-(methoxymethoxy)phenyl]-6H-[1]benzopyrano[4',3':4,5]pyrrolo[2,1-a]isoquinolin-6-one (17)
A solution of DDQ (66.3 mg, 0.292 mmol) in dichloromethane (10 mL) was added dropwise to a solution of 16 (182 mg, 0.280 mmol) in dichloromethane (20 mL) at room temperature. After being refluxed for 30 h, the mixture was cooled to room temperature and evaporated. The residue was purified by column chromatography (dichloromethane-ethyl acetate = 20:1) to give 17 as colorless solid (158 mg, 87% 4.2.8. 3-Hydroxy-14-(3-hydroxy-4-methoxyphenyl)-2,11,12-trimethoxy-6H-[1]benzopyrano[4',3':4,5]pyrrolo[2,1-a]isoquinolin-6-one (lamellarin α) (1) Under an argon atmosphere, a heptane solution of BCl 3 (1.0 M, 278 µL, 0.278 mmol) was added dropwise to a solution of 17 (30.0 mg, 0.0463 mmol) in dichloromethane (3.0 mL) at -78 °C. After being stirred for 30 min at this temperature, the reaction mixture was allowed to warm to 0 °C and stirred for an additional 3 h. The mixture was quenched with saturated aqueous NaHCO 3 and the precipitate thus formed was collected by filtration, washed with water, and dried under reduced pressure. The residue was purified by column chromatography over Sephadex LH-20 (acetone-methanol = 1:1) to give 1 as pale gray powder (23.3 mg, 98%). Mp > 300 °C (sealed capillary) (lit. 10 Under an argon atmosphere, a solution of 2,2,2-trichloroethyl chlorosulfate (38.9 mg, 0.157 mmol) in dichloromethane (3 mL) was added dropwise to a mixture of 18 (67.8 mg, 0.121 mmol), DMAP (14.7 mg, 0.121 mmol), and triethylamine (25.2 µL, 0.181 mmol) in dichloromethane (6 mL) at 0 °C. After being stirred for 1 h at this temperature, the reaction mixture was allowed to warm to room temperature and stirred for an additional 9 h. The mixture was quenched with water and the product was extracted with dichloromethane. The extract was washed with water and brine, dried over Na 2 SO 4 , and evaporated. The residue was purified by column chromatography (hexaneethyl acetate = 1:1) to give 19 as colorless solid (84.0 mg, 90% Under an argon atmosphere, a mixture of 20 (50.0 mg, 0.0686 mmol), ammonium formate (25.9 mg, 0.411 mmol), zinc (powder, 13.5 mg, 0.206 mmol), methanol (20 mL), and THF (20 mL) was stirred for 15 h at room temperature and passed through a pad of Celite. The filtrate was evaporated and the residue was purified successively by column chromatography over Silica Gel 60N (ethyl acetate-methanol = 3:1), column chromatography over Amberlite IRC-50 (Na + form) (ethyl acetate-methanolwater = 1:1:1), and column chromatography over Sephadex LH-20 (ethyl acetate-methanol = 1:1) to give 2 as pale yellow powder (38.1 mg, 90% 4.2.13. 8,9-Dihydro-3-Hydroxy-2,11,12-trimethoxy-14-[4-methoxy-3-(methoxymethoxy) , 2H), 3.27 (s, 3H), 3.43 (s, 3H), 3.78 (s, 3H) Sodium 8,9-dihydro-14-(3-hydroxy-4-methoxyphenyl)-2,11,12-trimethoxy-6-oxo-6H-[1]benzopyrano[4',3':4,5]pyrrolo[2,1-a]isoquinolin-3-yl  sulfate (lamellarin U 20-sulfate) (3) According to the procedure described for the preparation of 2, compound 23 (100 mg, 0.138 mmol) was reacted with zinc (27.0 mg, 0.413 mmol) and ammonium formate (52.0 mg, 0.825 mmol) to give 3 as pale yellow powder (60.0 mg, 71% According to the procedure described for the preparation of 18, compound 17 (100 mg, 0.154 mmol) was hydrogenolyzed over palladium carbon (Pd: 10%, 20 mg) for 7 h. After chromatographic purification (dichloromethane-ethyl acetate = 20:1-1:1), 24 was obtained as colorless solid (78.2 mg, 91% 
